Special Investigation of Pregabalin for Fibromyalgia (Regulatory Post Marketing Commitment Plan)

• Status: Completed
• Trial end date: 2017-07-01
• Target enrollment: 0
• Participant gender: All

Summary

To collect the efficacy and safety information of Pregabalin on Fibromyalgia patients related to their appropriate use in daily practice.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Pfizer; Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
• Treatments: Pregabalin

Criteria

Inclusion Criteria:

• Clinical diagnosis of Fibromyalgia

• Pregabalin naive patient

Exclusion Criteria:

• Clinical diagnosis of neuropathic pain